Stay updated with breaking news from 00484m10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stock analysts at StockNews.com initiated coverage on shares of Acorda Therapeutics (NASDAQ:ACOR – Get Free Report) in a research note issued to investors on Sunday. The brokerage set a “buy” rating on the biopharmaceutical company’s stock. Acorda Therapeutics Stock Down 24.9 % ACOR stock opened at $0.66 on Friday. The firm has a 50-day moving […]
StockNews.com initiated coverage on shares of Acorda Therapeutics (NASDAQ:ACOR – Free Report) in a research note issued to investors on Tuesday morning. The firm issued a buy rating on the biopharmaceutical company’s stock. Acorda Therapeutics Price Performance ACOR opened at $16.55 on Tuesday. The business’s 50-day moving average is $13.88 and its two-hundred day moving […]
StockNews.com started coverage on shares of Acorda Therapeutics (NASDAQ:ACOR – Free Report) in a report published on Sunday. The firm issued a buy rating on the biopharmaceutical company’s stock. Acorda Therapeutics Stock Performance Shares of ACOR opened at $14.23 on Friday. The company has a debt-to-equity ratio of 3.07, a quick ratio of 1.21 and […]
StockNews.com initiated coverage on shares of Acorda Therapeutics (NASDAQ:ACOR – Free Report) in a research note issued to investors on Saturday morning. The brokerage issued a buy rating on the biopharmaceutical company’s stock. Acorda Therapeutics Stock Performance Shares of ACOR opened at $15.09 on Friday. The company has a quick ratio of 1.21, a current […]
StockNews.com started coverage on shares of Acorda Therapeutics (NASDAQ:ACOR – Free Report) in a report issued on Friday. The brokerage issued a buy rating on the biopharmaceutical company’s stock. Acorda Therapeutics Stock Performance NASDAQ:ACOR opened at $15.29 on Friday. The company has a fifty day moving average of $11.04 and a two-hundred day moving average […]